Federated Hermes
CELL

Federated Hermes’s PhenomeX Inc. Common Stock CELL Stock Holding History

Federated Hermes’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,304
Closed -$3.58K – 2246
2023
Q2 		$3.58K Sell
7,304
-156,183
-96% -$128K ﹤0.01% 1941
2023
Q1 		$190K Sell
163,487
-1,971,529
-92% -$3.6M ﹤0.01% 1594
2022
Q4 		$5.72M Sell
2,135,016
-40,760
-2% -$107K 0.02% 661
2022
Q3 		$6.22M Sell
2,175,776
-331,365
-13% -$1.41M 0.02% 632
2022
Q2 		$12.5M Buy
2,507,141
+463,153
+23% +$2.43M 0.03% 504
2022
Q1 		$14.5M Buy
2,043,988
+1,893,899
+1,262% +$15.7M 0.03% 522
2021
Q4 		$2.73M Buy
+150,089
New +$3.24M 0.01% 971
2021
Q3 		– Sell
-200,000
Closed -$8.96M – 2349
2021
Q2 		$8.96M Hold
200,000
– – 0.02% 695
2021
Q1 		$10M Hold
200,000
– – 0.02% 658
2020
Q4 		$17.9M Hold
200,000
– – 0.04% 501
2020
Q3 		$15.3M Buy
+200,000
New +$12.7M 0.04% 474

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes's CELL Position: Q3 2023 in Review

Federated Hermes sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 7,304 shares — an estimated $3.58K sold.

Federated Hermes first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $17.9M in Q4 2020. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Federated Hermes reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Federated Hermes sold 7,304 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $3.58K.
  • Federated Hermes first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Federated Hermes's PhenomeX Inc. Common Stock position peaked at $17.9M in Q4 2020.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.